An emerging technology for early cancer diagnosis could lead to innovative clinical trial strategies, novel drug combinations and new drug targets.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Morrison, C. Search for liquid biopsy grail points the way to drug discovery and development gems. Nat Rev Drug Discov 16, 373–374 (2017). https://doi.org/10.1038/nrd.2017.96
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.96